T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Paycom
PAYC
$9.52B
| $13.8M | ﹤0.01% |
69,444
-49,045
| -41% | -$9.38M |
|
1052
American Airlines Group
AAL
$9.97B
| $13.5M | ﹤0.01% |
876,505
+9,857
| +1% | +$143K |
|
1053
United Parks & Resorts
PRKS
$2.01B
| $12.9M | ﹤0.01% |
230,177
+1,325
| +0.6% | +$67.2K |
|
1054
Boston Properties
BXP
$10.8B
| $12.8M | ﹤0.01% |
195,553
+800
| +0.4% | +$53K |
|
1055
Markel Group
MKL
$22.8B
| $12.7M | ﹤0.01% |
8,336
+359
| +5% | +$526K |
|
1056
Caesars Entertainment
CZR
$6.04B
| $12.7M | ﹤0.01% |
289,315
-139,782
| -33% | -$6.05M |
|
1057
Tarsus Pharmaceuticals
TARS
$3.07B
| $12.6M | ﹤0.01% |
+347,683
| New | +$10.2M |
|
1058
TripAdvisor
TRIP
$1.26B
| $12.6M | ﹤0.01% |
454,319
-13,640
| -3% | -$331K |
|
1059
Petrobras
PBR
$115B
| $12.5M | ﹤0.01% |
824,377
| – | – |
|
1060
Owens Corning
OC
$12.3B
| $12.4M | ﹤0.01% |
74,470
+9,584
| +15% | +$1.46M |
|
1061
Belden
BDC
$5.39B
| $12.4M | ﹤0.01% |
133,469
+930
| +0.7% | +$75.8K |
|
1062
Robert Half
RHI
$4.25B
| $12.3M | ﹤0.01% |
155,439
-2,571
| -2% | -$207K |
|
1063
C.H. Robinson
CHRW
$17.1B
| $12.3M | ﹤0.01% |
161,314
+111
| +0.1% | +$8.68K |
|
1064
Zoom
ZM
$30.8B
| $12M | ﹤0.01% |
183,119
-25,476
| -12% | -$1.7M |
|
1065
Ollie's Bargain Outlet
OLLI
$4.73B
| $11.9M | ﹤0.01% |
149,033
+7,714
| +5% | +$583K |
|
1066
Campbell Soup
CPB
$6.94B
| $11.8M | ﹤0.01% |
266,180
+357
| +0.1% | +$15.4K |
|
1067
Ambev
ABEV
$43.5B
| $11.8M | ﹤0.01% |
4,763,220
| – | – |
|
1068
DaVita
DVA
$11.6B
| $11.8M | ﹤0.01% |
85,286
+533
| +0.6% | +$63.9K |
|
1069
Affiliated Managers Group
AMG
$9.57B
| $11.7M | ﹤0.01% |
69,919
+2,190
| +3% | +$340K |
|
|
BBOT
1070
BridgeBio Oncology
BBOT
$755M
| $11.7M | ﹤0.01% |
+1,130,677
| New | +$11.7M |
|
1071
Franklin Resources
BEN
$17.1B
| $11.6M | ﹤0.01% |
412,881
+35,577
| +9% | +$980K |
|
1072
LCI Industries
LCII
$2.6B
| $11.6M | ﹤0.01% |
94,228
-6,916
| -7% | -$814K |
|
1073
Wave Life Sciences
WVE
$1.02B
| $11.5M | ﹤0.01% |
1,861,254
+233,891
| +14% | +$1.17M |
|
1074
Freshpet
FRPT
$3.48B
| $11.5M | ﹤0.01% |
98,924
+65,868
| +199% | +$6.37M |
|
1075
Fomento Económico Mexicano
FMX
$40B
| $11.4M | ﹤0.01% |
87,798
-35,802
| -29% | -$4.68M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.